Psychiatry and Clinical Psychopharmacology
Original Articles

Clinical Efficacy of Sleep Induction Intervention in Conjunction with Lorazepam in Managing Insomnia Disorder

1.

Department of Clinical Psychology, Lishui Second People’s Hospital, Zhejiang Province, China

2.

Department of Counseling , Lishui Second People’s Hospital, Zhejiang Province, China

3.

Department of Nursing , Lishui Second People’s Hospital, Zhejiang Province, China

4.

Department of Operating Room, Lishui People’s Hospital, Zhejiang Province, China

Psychiatry and Clinical Psychopharmacology 2025; 35: 1-5
DOI: 10.5152/pcp.2025.241003
Read: 77 Downloads: 34 Published: 18 March 2025

Background: This study investigates the clinical efficacy of a combined treatment approach involving sleep induction intervention and lorazepam in managing insomnia disorder.

Methods: This study enrolled a sample of 150 individuals diagnosed with insomnia disorder, consecutively admitted to our clinic from June 2021 to June 2023. Following randomization, the participants were divided into 2 groups: observation and control groups. Both groups were administered lorazepam treatment, with the observation group receiving sleep induction intervention and the control group receiving routine nursing. After the 4-week treatment period, relevant observation indicators were assessed to evaluate the efficacy of sleep improvement in both patient intervention groups.

Results: Compared to the control group that received only lorazepam treatment, the observation group, who underwent sleep induction intervention, showed a better treatment effectiveness rate, sleep quality, and psychological state regarding the treatment of sleep disorders (P < .05).

Conclusion: Sleep induction intervention can improve the overall treatment effectiveness rate of sleep disorders, enhance sleep quality, and alleviate symptoms of anxiety and depression.

Cite this article as: Chen J, Zhang Y, Min G, et al. Clinical efficacy of sleep induction intervention in conjunction with lorazepam in managing insomnia disorder. Psychiatry Clin Psychopharmacol. 2025;35(1):1-5.

Files
EISSN 2475-0581